Insider transactions

ARMISTICE CAPITAL, LLC

CIK 1601086 · last filed 2023-06-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$226.97M
Companies
15
Total Filings
83
Lifetime Open-Market Net
$140.94M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

CERC price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
510 MADISON AVENUE, 7TH FLOOR
NEW YORK, NY 10022
Phone
(212) 231-4932
State of Incorporation
DE
Related Filers
Steven Boyd — 239 joint filings, latest 2023-06-28
Armistice Capital Master Fund Ltd. — 233 joint filings, latest 2023-06-28
Cerecor Inc. — 108 joint filings, latest 2023-06-28
LM FUNDING AMERICA, INC. — 8 joint filings, latest 2026-08-14
IRONWOOD PHARMACEUTICALS INC — 7 joint filings, latest 2026-08-14
SPECTRUM PHARMACEUTICALS INC — 7 joint filings, latest 2023-02-14
Citius Pharmaceuticals, Inc. — 5 joint filings, latest 2022-02-15
CYTRX CORP — 3 joint filings, latest 2024-02-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVTX Director 3,191 $6.90 $22.0K -$1.94M 6 2023-06-28
Avalo Therapeutics, Inc. (CERC) Delisted Director 39,662,442 $2.93 $116.21M $51.07M 15 2021-08-06
Vyome Holdings, Inc (RSLS) Delisted 10%+ Owner 48 $15.68 $753 $0 1 2021-06-29
EYEG Director 6,693,202 $33.78 $226.13M $36.97M 10 2021-01-08
AYTU Director 133,334 $1.90 $253.3K $24.00M 1 2020-12-15
TENX Director 2,519 $1.69 $4.3K $277.6K 2 2020-09-09
Vaxart, Inc. (VXRT) Delisted Director 16,800,000 $0.32 $5.38M -$1.57M 1 2020-05-29
AMAG PHARMACEUTICALS, INC. (AMAG) Delisted 10%+ Owner 4,468,000 — — $1.25M 2 2020-03-18
Traws Pharma, Inc. (ONTXW) Delisted 10%+ Owner 1,633,404 $0.07 $109.6K -$39.0K 1 2019-09-25
ACHV 10%+ Owner 81,909 $6.79 $556.6K -$404.5K 1 2019-06-13
Del Frisco's Restaurant Group, Inc. (DFRG) Delisted 10%+ Owner 6,525,000 — — $29.99M 11 2019-06-06
Valeritas Holdings Inc. (VLRX) Delisted 10%+ Owner 2,116,000 — — $465.8K 4 2019-05-28
CASSAVA SCIENCES INC (PTIE) Delisted 10%+ Owner 1,651,340 — — -$2.02M 1 2018-10-05
Fresh Tracks Therapeutics, Inc. (VICL) Delisted 10%+ Owner 862,146 — — $69.2K 1 2018-06-22
Avalo Therapeutics, Inc. (CERCW) Delisted Director 32,440,000 — — $2.82M 8 2018-04-23

Recent Filings · Page 7 of 9

83 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-11-29 Valeritas Holdings Inc. (VLRX) Delisted Buy (P) +450,000 $161.6K EDGAR
2018-11-26 Avalo Therapeutics, Inc. (CERC) Delisted Buy (P) +150,000 $538.2K EDGAR
2018-11-16 EYEG Buy (P) +1,080,000 $484.2K EDGAR
2018-11-16 Del Frisco's Restaurant Group, Inc. (DFRG) Delisted Buy (P) +234,000 $1.45M EDGAR
2018-11-15 Avalo Therapeutics, Inc. (CERC) Delisted Buy (P) +93,942 $361.7K EDGAR
2018-11-01 Avalo Therapeutics, Inc. (CERC) Delisted Buy (P) +17,958 $70.4K EDGAR
2018-10-05 CASSAVA SCIENCES INC (PTIE) Delisted Sell (S) −1,537,980 -$2.02M EDGAR
2018-09-14 Del Frisco's Restaurant Group, Inc. (DFRG) Delisted Buy (P) +96,000 $775.3K EDGAR
2018-06-22 Fresh Tracks Therapeutics, Inc. (VICL) Delisted Buy (P) +55,086 $69.2K EDGAR
2018-05-30 EYEG Buy (P) +174,825 $100.3K EDGAR
Showing 61–70 of 83
Page 7 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.